FDA Commissioner announces Avastin decision FDA Commissioner Margaret A. Hamburg,
FDA Commissioner announces Avastin decision
FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency s approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.